Teladoc Health (TDOC) is scheduled to report Q1 earnings on April 29, 2026. Analysts estimate EPS of $-0.36 and quarterly revenue of $611.60M.
In the most recent quarter (Q4), Teladoc Health reported EPS of $-0.14, beating estimates of $-0.21 by 0.33%. Revenue came in at $642.27M, exceeding the estimate of $634.76M by 0.01%.
Teladoc Health has beaten EPS estimates in 7 consecutive quarters.
Over the last 4 quarters, Teladoc Health has averaged an EPS surprise of 0.33% and a revenue surprise of 0.01%.
Analyze the earnings history of Teladoc Health using advanced sorting and filters.
The chart below shows Teladoc Health's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Teladoc Health's reported revenue compared to analyst estimates over recent quarters.
Teladoc Health (TDOC) is scheduled to report earnings on April 29, 2026. The last reported earnings were for reported on February 25, 2026 for Q4.
The Actual EPS was $-0.14, which beat the estimate of $-0.21.
The Actual Revenue was $642.27M, which beat the estimate of $634.76M.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-02-25 | $-0.14 | $-0.21 | 33.3 % |
| Q3 | 2025-10-29 | $-0.20 | $-0.24 | 16.7 % |
| Q2 | 2025-07-29 | $-0.19 | $-0.29 | 34.5 % |
| Q1 | 2025-04-30 | $-0.19 | $-0.36 | 47.2 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-02-25 | $642.27M | $634.76M | 1.18 % |
| Q3 | 2025-10-29 | $626.44M | $630.93M | -0.71 % |
| Q2 | 2025-07-29 | $631.90M | $621.94M | 1.60 % |
| Q1 | 2025-04-30 | $629.40M | $619.23M | 1.64 % |